Harald Knorr

Clinical determinants of long-term survival in metastatic uveal melanoma

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancer Immunology, Immunotherapy.

Clinical determinants of long-term survival in metastatic uveal melanoma

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancer Immunology, Immunotherapy.

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

M. Weichenthal, J. Utikal, C. Berking, 2022, Cancers.

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancers.

Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial

M. Weichenthal, J. Utikal, D. Schadendorf, 2023, Frontiers of medicine.

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy

A. Wessely, Harald Knorr, B. Schuler-Thurner, 2024, Journal for ImmunoTherapy of Cancer.

Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis

A. Petzold, A. Wessely, M. Erdmann, 2023, AntiCancer Research.